AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06751472 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: WOMAC (Western Ontario and McMaster Universities Arthritis Index) scale
Description: It includes 24 questions under three sub-headings as pain, stiffness and physical function
Study NCT06755112 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo cream
Description: Placebo cream application
Study NCT05024071 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Wushu athletes in the experimental group used a Swiss ball for 12 weeks of core strength training
Description: The experimental group was given 12 weeks of core strength training, divided into 6 types~1. Static action under steady state.~2. No load movement in steady state.~3. Static action under unstable state.~4. Movement to overcome its own resistance in an unstable state.~5. Free strength exercise in unstable state.~6. Core explosive power exercise under unstable conditions.
Study NCT05024071 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Wushu athletes in the experimental group used a balance board for 12 weeks of core strength training
Description: The experimental group was given 12 weeks of core strength training, divided into 6 types~1. Static action under steady state.~2. No load movement in steady state.~3. Static action under unstable state.~4. Movement to overcome its own resistance in an unstable state.~5. Free strength exercise in unstable state.~6. Core explosive power exercise under unstable conditions.
Study NCT04912466 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Biological: IBI322
Description: Recombinant anti-human CD47/PD-L1 bispecific antibody injection
Study NCT05482984 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: video-recorded role-play and guided reflection
Description: The experimental group was divided into 6 teams. Before the course, the teacher in charge and each group developed six scenarios: restraint, suicidal intent, respiratory distress, chronic heart failure, medication refusal, and accidental amputation. The researcher guided each group to write scripts about the clinical situations (30 minutes), create role-play videos (50 minutes), and share literature that was helpful in understanding this context (30 minutes). Each student played a role in the filming process. The final film was viewed by all the students during class. Each live class session was 50 minutes in length, with one session per week for 6 weeks. All students were asked to attend six video-viewing sessions and participate in a reflective discussion.
Study NCT06755112 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: active cream
Description: Active cream application
Study NCT06755398 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Exercise
Description: During the exercises based on the protocol developed by the Royal Dutch Society for Physical Therapy (KNGF) following anterior cruciate ligament (ACL) surgery, additional cognitive tasks will be assigned to the patients.
Study NCT06755398 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: The protocol developed by the Royal Dutch Society for Physical Therapy (KNGF) will be applied following anterior cruciate ligament (ACL) surgery.
Study NCT06754228 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotic Agent
Description: Bacillus coagulans JBI-YZ6.3 (BC4U)
Study NCT06754228 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotic Agent
Description: An escalating dose cross-over design: Participants are fed 0 mg, 100 mg, 200 mg, and 400 mg on different clinic visits.
Study NCT06752291 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: water flosser
Description: A water flosser will be provided for use throughout the study, with participants instructed to use it once daily, specifically at the end of the day before bedtime.
Study NCT06754774 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Shoulder Endurance Test
Description: Each patient receive the same intervention, the Shoulder Endurance Test (SET). The Shoulder Endurance Test assesses the endurance of the shoulder muscles in an open kinetic chain.
Study NCT06755086 — intervention group
Intervention type: DRUG
Intervention: 18-FDG
Description: All study participants will undergo one 18F-FDG PET/ CT scan.
Study NCT06752434 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation
Description: active DBS with optimal stimulating parameters
Study NCT05416489 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: C-MAC videolayngoscopy technique
Description: Endotracheal tube will be removed before percutaneous tracheostomy using a C-MAC videolaryngoscopy.
Study NCT05416489 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Laryngoscopy technique
Description: Endotracheal tube will be removed before percutaneous tracheostomy using a laryngoscopy
Study NCT06180486 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mindfulness Meditation Intervention
Description: The mindfulness intervention is a scripted, \~12min audio recording based on core tenets of mindfulness meditation and contextualized for patients undergoing total knee arthroplasty. It teaches sustained attention on the present, body awareness, acceptance of the body's current state, and transformational strategies to cope with emotional or physical stimuli as they arise. It has been created by the study team based on the teachings of Jon Kabat Zinn (founder of mindfulness meditation) and the PI's history teaching yoga and meditation. Patients will be encouraged to review the audio recording once a week.
Study NCT06180486 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Mindfulness Meditation Intervention
Description: The mindfulness intervention is a scripted, \~12min audio recording based on core tenets of mindfulness meditation and contextualized for patients undergoing total knee arthroplasty. It teaches sustained attention on the present, body awareness, acceptance of the body's current state, and transformational strategies to cope with emotional or physical stimuli as they arise. It has been created by the study team based on the teachings of Jon Kabat Zinn (founder of mindfulness meditation) and the PI's history teaching yoga and meditation. Patients will be encouraged to review the audio recording once a week.
Study NCT04900792 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ferumoxytol injection
Description: Ferumoxytol is an iron replacement product FDA approved for treatment of iron deficiency anemia in adult patients with chronic kidney disease (CKD). This trial uses the FDA approved dosage (512 mg iron) for iron-deficiency anemia in CKD.
Study NCT04900792 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pharmacological ascorbate
Description: Intravenous ascorbate
Study NCT04900792 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: External beam radiation therapy
Description: Photon based, focal radiation therapy delivered consistent with national guidelines, standard for treatment of GBM.
Study NCT04900792 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: Temozolomide is a cytotoxic alkylating agent administered orally that penetrates well into the central nervous system. It is a standard-of-care treatment for GBM.
Study NCT04806880 — intervention group
Intervention type: DEVICE
Intervention: Web-application
Description: support for olfactory coaching consisting of the inhalation of fragrant essential oils.
Study NCT05934084 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyles Implemented-Survivorship Care Plan (LS-SCP)
Description: Patients in the experimental arm will follow the planned intervention (Survivorship Care Plan (SCP), nutritional plan, physical activity) for 6 months. A bi-monthly automatic call to assess the compliance at the experimental arm (LS-SCP, Lifestyles implemented-Survivorship Care Plan) will be performed.
Study NCT06450132 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atropine Ophthalmic
Description: 0.05% atropine ophthalmic solution
Study NCT06450132 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MiSight 1-day disposable contact lenses
Description: soft multifocal contact lenses
Study NCT05338970 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Patritumab Deruxtecan
Description: Intravenous administration, 5.6 mg/kg every 3 weeks (q3W)
Study NCT05338970 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Platinum-based chemotherapy
Description: Intravenous, pemetrexed 500 mg/m\^2 plus either cisplatin (75 mg/m\^2) or carboplatin (target area under the plasma concentration time curve of 5 \[AUC5\] by using the Calvert formula) q3W
Study NCT05942001 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS-5041
Description: HRS-5041 was given oral administration, qd, at a 28-day cycle. Patients may continue to use HRS-5041 until disease progression or unacceptable toxicity occurs.
Study NCT05699733 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: mechanical traction for knee joint
Description: All participants will receive a single session per condition. This session will consist of continuous mechanical knee traction for 30 minutes while the participant assumes a supine position with the treated limb in semiflexion (30° of flexion). the treated limb will be supported using the traction bed's table that is used for this purpose. The knee position angle will be measured by a standard goniometer. Pelvis and thigh straps will be used to fix the body and prevent slippage during the application of the traction force. A customized leg cuff will be placed around the lower leg (above the ankle joint), and a traction rope will be extending horizontally from the cuff to the traction device. 48 hours of washing out will separate the sessions of different conditions
Study NCT04780568 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Osimertinib
Description: Given PO
Study NCT04780568 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tegavivint
Description: Given IV
Study NCT05109299 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Miswak toothpaste
Description: Dabur Meswak is scientifically formulated herbal toothpaste with pure extract of the Miswak plant 'Salvadore Persica'
Study NCT05109299 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Fluoride toothpaste
Description: 1450 ppm fluoride toothpaste
Study NCT05071118 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pregabalin 150mg
Description: pregabalin patients (group P) received capsules containing 150mg of pregabalin in the ward then transferred to OR to receive spinal anesthesia before surgery
Study NCT05071118 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: The patients received placebo capsules in the ward Then transferred to OR to receive spinal anesthesia before surgery .
Study NCT05777642 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Oxygen Nanobubble
Description: This contains oxygenated nanobubbles made from lecithin and natural flavourings (Liquorice, glycerol, and citric acid)
Study NCT05777642 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Oxygen Nanobubble
Description: This contains oxygenated nanobubbles made from lecithin and natural flavourings (Liquorice, glycerol, and citric acid)
Study NCT05777642 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Placebo
Description: This does not contain nanobubbles and is made from natural flavourings (Liquorice, glycerol, and citric acid)
Study NCT05777642 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: This does not contain nanobubbles and is made from natural flavourings (Liquorice, glycerol, and citric acid)
Study NCT06176196 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VX-548
Description: Tablets for oral administration.
Study NCT06176196 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Tablets for oral administration.
Study NCT06530758 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Altered ASRS format, without shading and with grouping
Description: Participants will be asked to complete the ASRS form without shading and with grouping.
Study NCT06530758 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Altered ASRS format, with shading and without grouping
Description: Participants will be asked to complete the ASRS form with shading and without grouping.
Study NCT06530758 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Altered ASRS format, without shading and without grouping
Description: Participants will be asked to complete the ASRS form without shading and without grouping.
Study NCT06229145 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pegloticase
Description: IV infusion
Study NCT06229145 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methotrexate
Description: Oral
Study NCT04843865 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Chinese Herbs
Description: Chinese Herbs
Study NCT05273723 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 5 Behavioral Change Techniques
Description: 1. Goal setting: set or agree on a goal defined in terms of behavior to be achieved. Example: Set the goal of walking 2,000 steps more per day.~2. Action planning: prompt detailed planning of performance of behavior (must include a setting \[walking to the mailbox\], frequency, duration, and intensity. Example: Develop a plan to walk today.~3. Self-Monitoring of behavior: establish a method for person to monitor and record their number of steps based on their Fitbit. Example: Did you check your Fitbit and record daily total number of steps?~4. Feedback on behavior: Monitor and provide informative or evaluative feedback on performance of the behavior (e.g. form, frequency, duration, intensity). Example: You walked 6,000 steps today.~5. Prompts/Cues: introduce or define environmental or social stimulus with the purpose of prompting or cueing the behavior. The prompt or cue would normally occur at the time or place of performance. Example: You planned to walk today in the park at 3pm.
Study NCT05155865 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Resynchronization with conduction system pacing
Description: Implantation of permanent pacemaker with conduction system pacing (preferably left bundle branch) with or without defibrillator lead placement
Study NCT05155865 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cardiac resynchronization therapy with biventricular stimulation
Description: Implantation of cardiac resynchronization therapy with biventricular stimulation with or without defibrillator lead placement
Study NCT05853848 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Postcard
Description: Postcard with phone number to call for help scheduling a mammogram.
Study NCT05904015 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Envafolimab combined with concurrent chemoradiotherapy (Hypofractionated radiotherapy)
Description: Envafolimab: 300mg SC d1,Q3W,2 cycles Cisplatin/carboplatin: Cisplatin: 75 mg/m2 IV d1,Q3W ,2 cycles or Carboplatin:AUC=5/6 IV d1,Q3W,2cycles Etoposide: 100mg/m2 IV d1,Q3W ,2 cycles Radiotherapy: Provide a prescription dose of 45Gy at a 95% PTV dose, with a single split dose of 3Gy, once a day, 5 times a week, for a total of 15 times.~Envafolimab maintenance: 300mg,SC, d1. Q3W, up to 2 years or until PD or intolerable.
Study NCT05904015 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Envafolimab combined with concurrent chemoradiotherapy (Conventional Radiotherapy)
Description: Envafolimab: 300mg SC d1,Q3W,2 cycles Cisplatin/carboplatin:Cisplatin:75 mg/m2 IV d1,Q3W ,2 cycles or Carboplatin:AUC=5/6 IV d1,Q3W,2cycles Etoposide: 100mg/m2 IV d1,Q3W ,2 cycles Radiotherapy: Provide a prescription dose of 60Gy at a 95% PTV dose, with a single split dose of 2Gy, once per day, 5 times per week, for a total of 30 times.~Envafolimab maintenance: 300mg,SC, d1. Q3W, up to 2 years or until PD or intolerable.
Study NCT05853848 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Letter
Description: Letter with phone number to call for help scheduling a mammogram.
Study NCT05853848 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Auto-dialer
Description: Auto-dialer with option to press button for help scheduling a mammogram.
Study NCT05853848 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Live call
Description: Live call offering help scheduling a mammogram.
Study NCT05842395 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin C
Description: Participants with distal radius fractures will take vitamin C supplementation with a daily dose of 1g orally for three months.
Study NCT05842395 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants with distal radius fractures will take daily Placebo orally for three months.
Study NCT04572048 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Single-day NRP Training
Description: NRP training course completed in one single day of 8 hours
Study NCT04572048 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: longitudinal NRP training
Description: NRP training course completed over one year by attending nine 30-minute modules.
Study NCT06201338 — intervention group
Intervention type: PROCEDURE
Intervention: Screening of preoperative frailty
Description: The day before the surgery, a multimodal evaluation is performed regarding :~Cognitive assessment: Mini mental State evaluation (MMSE) test Physical functional assessment: Chair raising Addiction assessment: Fagerstrom Assessment of the social environment: environmental assessment Nutritional assessment: Grip test Quality of life: completion of SF 36 scale and QOR15 scale
Study NCT06494293 — intervention group
Intervention type: OTHER
Intervention: Data Collection
Description: Collection of medical data from MICU intervention file and patient medical files from participating centres
Study NCT05805592 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Screen-to-Move-Program (STEP)
Description: It is planned as 6 sessions, 1 session per week for children and parents. The program will be introduced to children and parents under the call with Screen-to-Move-Program (STEP).
Study NCT05154279 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Terlipressin
Description: intramyometrial terlipressin vs carbitocin vs saline as placebo
Study NCT05154279 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Terlipressin
Description: intramyometrial terlipressin vs carbitocin vs saline as placebo
Study NCT05151380 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: CO2 laser MonaLisa Touch ®
Description: 3 sessions of SmartXide fractional CO2 laser via the MonaLisa Touch® device, spaced 4 weeks apart, will be performed. An additional comfort session will be performed at 1 year if needed.~The handpiece of the MonaLisa Touch® device is applied to the vaginal walls with a 360° scan, between 800 and 1100µs, to the vaginal orifice
Study NCT06354634 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resin polymer (NuSmile Bioflx) crown
Description: Resin polymer (NuSmile Bioflx)crown
Study NCT06354634 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stainless steel crown
Description: Stainless steel crown
Study NCT05570786 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gestrinone
Description: The intradermal gestrinone/placebo pellet will be inserted on the same day as the levonorgestrel intrauterine hormonal device (Kyleena®)
Study NCT05570786 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subdermal implant-bioabsorbable placebo pellet (cholesterol)
Study NCT05795140 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iptcaopan 200 mg
Description: Open label, participant specific kits, hard gelatin capsules to be taken twice a day
Study NCT06223958 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OTX-TKI (axitinib implant)
Description: Intravitreal Injection of OTX-TKI (axitinib implant)
Study NCT06223958 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Aflibercept
Description: Injection of 2mg (0.05mL) of aflibercept
Study NCT06372769 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: electromyograph and kinesiograph
Description: The sEMG of the anterior temporalis (TA), masseter (MM), sternocleidomastoid (cervical group, CG), and digastric (DA) were recorded simultaneously with an sEMG device (K7/EMG, USA) using disposable silver/silver chloride bipolar surface electrodes.~First, sEMG was conducted on four pairs of muscles (TA, MM, CG, and DA) in the MPP, and subjects were guided to maintain the face and jaw as relaxed as possible. To determine the relative efficiency of muscle function, the second test was performed to measure the sEMG of TA and MM during the maximal biting force against natural dentition. In the third test, subjects were guided to clench three times to monitor early motor unit recruitment as they closed from rest through freeway space to initial tooth contact.~Kinesiographic recordings were performed using a kinesiograph (K7/Computerized Mandibular Scanning (CMS), USA) that measured the maximum mouth opening (MMO) and opening and closing velocities.
Study NCT06273423 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: OULA, Mind-body Physical Activity
Description: Group dance fitness program with focus on the mind-body connection
Study NCT05410938 — intervention group
Intervention type: DRUG
Intervention: Chemotherapy
Description: Triweekly chemotherapy with bevacizumab versus intraperitoneal chemotherapy without bevacizumab
Study NCT05526105 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Gastric Ultrasound
Description: Gastric ultrasound in the supine and right lateral decubitus position for patients going for operative intervention with a protected airway.